Niranjan Sardesai

Niranjan Sardesai

Company: Geneos Therapeutics

Job title: Chief Executive Officer


Targeting Unique Neoantigens From Individual Patient Tumors To Develop Novel Treatment For Cancer 2:45 pm

• Optimized DNA plasmid containing encoded neoantigens, used in combination with IL-2 to boost T cell response • Electroporation-based delivery system for enhanced and efficient plasmid uptake to allow optimal antigen production • Combination therapy shows robust functional antigen specific CD4+ and CD8+ killer T cellsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.